Le Lézard
Classified in: Health
Subjects: TDS, SBS, FVT

Cannabusiness Sun Valley Health Partners with Cannabis Industrial Marketplace Phoenix B2B Expo


PHOENIX, Jan. 27, 2020 /PRNewswire/ -- Cannabis Industrial Marketplace is pleased to welcome Sun Valley Health as an expo sponsor to our Arizona B2B Cannabusiness Expo in Phoenix on Feb. 13 - 14, 2020. Sun Valley Health aims to optimize the certification process by putting patients first, and to provide franchise opportunities for those interested in operating their own clinic.

The couple behind Sun Valley, Dustin and Andrea Klein, have grown to five Arizona locations, serving over 20 percent of Arizona medical marijuana patients, and have opened in Las Vegas. In addition to serving over 20,000 patients a year, Sun Valley has launched their own CBD products: Sun Valley Science; a series of full-spectrum products, and Sollievo; a line of terpene-enriched, no-THC tinctures.

"Cannabis Industrial Marketplace" provides online and expo cannabusiness experiences. The 2020 Expo series stretches throughout the US focusing on emerging markets with the online resource CannabisImp.com providing access to over 4,000 Cannabusiness suppliers, backed by Strategic Market Solutions, LLC, a B2B lead generation company.

Attendees at our Arizona expo can discuss nationwide franchise opportunities at Sun Valley Franchising's booth, but those looking to obtain their medical marijuana card in Arizona will also be able to visit the expo's certification clinic.

According to Andrea Klein, the five-step clinic process models traditional medicine, putting patients more at-ease:

  1. Paperwork
  2. See first doctor
  3. See second doctor
  4. Upload application to state website with help of staff member
  5. Get paperwork within 2 - 48 hours after appointment

The process takes anywhere from 45 minutes to one hour. "It's similar to traditional medicine, but with an alternative product that is better for [patients]," she said.

Adding, patients can expect their paperwork to be approved within 48 hours. "They get their card as quickly as possible," Klein said. "If it's a hassle, we handle it," she added. Appointments can be scheduled online https://www.sunvalleyhealth.com/cimp/ or at Booth 156 at the expo.

Additionally, attendees interested in Sun Valley franchise opportunities can look to Booth 100, and to attend Dustin Klein's seminar "A Proven Strategy for Starting a Cannabis Business with Limited Regulations & Low Investment" on Feb. 13th at 1:30 p.m. to learn more.

To purchase passes, head to azcannabisexpo.com/tickets.

Contact: Jen Wynn ? [email protected] - 636-346-1266 - Cannabis Industrial Marketplace - 2113 W Vienna Clio, MI 48420 

SOURCE Cannabis Industrial Marketplace


These press releases may also interest you

at 10:02
Boston Institute of Biotechnology, LLC (BIB) in collaboration with BIBo-Biopharma, proudly announces the successful completion of a groundbreaking 30,000L fermentation run, marking a significant milestone in biotechnology history....

at 10:00
Minister Responsible for Relations with the First Nations and the Inuit Ian Lafrenière today submitted in the National Assembly the third annual report on the administration of the Act to authorize the communication of personal information to the...

at 10:00
Cobb Outpatient Detox has opened a new facility in Marietta, GA, providing outpatient drug and alcohol detox services. The center aims to assist individuals in overcoming addiction while balancing their work and family commitments. Located near major...

at 10:00
A new report from the Health Care Cost Institute (HCCI) shows that, even with fluctuations in 2020 and 2021, per person health care spending grew from 2018 to 2022. Over the five years, average prices increased by 14% and utilization went up by about...

at 10:00
BioInnovation Institute (BII), an international non-profit foundation, incubating and accelerating world-class life science research, today announces the launch of the BII & Science Translational Medicine Prize for Innovations in Women´s Health and...

at 10:00
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 for multiple advanced solid tumors will be presented...



News published on and distributed by: